Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Herpes simplex Infection

Free Subscription Articles published in J Virol Retrieve available abstracts of 90 articles: HTML format

Single Articles

March 2024
1. JAGGI U, Matundan HH, Oh JJ, Ghiasi H, et al
   Absence of CD80 reduces HSV-1 replication in the eye and delays reactivation but not latency levels.
   J Virol. 2024;98:e0201023.
   PubMed     Abstract available
   
   
   
2. OUWENDIJK WJD, Roychoudhury P, Cunningham AL, Jerome KR, et al
   Reanalysis of single-cell RNA sequencing data does not support herpes simplex virus 1 latency in non-neuronal ganglionic cells in mice.
   J Virol. 2024 Mar 6:e0185823. doi: 10.1128/jvi.01858.
   PubMed     Abstract available
   
   
   February 2024
3. DOCHNAL SA, Whitford AL, Francois AK, Krakowiak PA, et al
   c-Jun signaling during initial HSV-1 infection modulates latency to enhance later reactivation in addition to directly promoting the progression to full reactivation.
   J Virol. 2024;98:e0176423.
   PubMed     Abstract available
   
   
   January 2024
4. BERGEMAN MH, Hernandez MQ, Diefenderfer J, Drewes JA, et al
   Individual herpes simplex virus 1 (HSV-1) particles exit by exocytosis and accumulate at preferential egress sites.
   J Virol. 2024 Jan 9:e0178523. doi: 10.1128/jvi.01785.
   PubMed     Abstract available
   
   
   December 2023
5. GRAMS TR, Edwards TG, Bloom DC
   A viral lncRNA tethers HSV-1 genomes at the nuclear periphery to establish viral latency.
   J Virol. 2023;97:e0143823.
   PubMed     Abstract available
   
   
   November 2023
6. VELUSAMY T, Singh N, Croft S, Smith S, et al
   The expression and function of HSV ICP47 and its promoter in mice.
   J Virol. 2023;97:e0110723.
   PubMed     Abstract available
   
   
   October 2023
7. WAISNER H, Lasnier S, Suma SM, Kalamvoki M, et al
   Effects on exocytosis by two HSV-1 mutants unable to block autophagy.
   J Virol. 2023;97:e0075723.
   PubMed     Abstract available
   
   
   
8. ZUBKOVIC A, Gomes C, Parchure A, Cesarec M, et al
   HSV-1 miRNAs are post-transcriptionally edited in latently infected human ganglia.
   J Virol. 2023;97:e0073023.
   PubMed     Abstract available
   
   
   
9. YOU H, Lin Y, Lin F, Yang M, et al
   Correction for You et al., "beta-Catenin Is Required for the cGAS/STING Signaling Pathway but Antagonized by the Herpes Simplex Virus 1 US3 Protein".
   J Virol. 2023 Oct 16:e0098423. doi: 10.1128/jvi.00984.
   PubMed    
   
   
   
10. YUAN H, You J, You H, Zheng C, et al
    Correction for Yuan et al., "Herpes Simplex Virus 1 UL36USP Antagonizes Type I Interferon-Mediated Antiviral Innate Immunity".
    J Virol. 2023 Oct 16:e0098323. doi: 10.1128/jvi.00983.
    PubMed    
    
    
    
11. HUANG J, You H, Su C, Li Y, et al
    Correction for Huang et al., "Herpes Simplex Virus 1 Tegument Protein VP22 Abrogates cGAS/STING-Mediated Antiviral Innate Immunity".
    J Virol. 2023 Oct 16:e0098223. doi: 10.1128/jvi.00982.
    PubMed    
    
    
    
12. ZHENG C
    Correction for Zheng, "Evasion of Cytosolic DNA-Stimulated Innate Immune Responses by Herpes Simplex Virus 1".
    J Virol. 2023 Oct 16:e0098123. doi: 10.1128/jvi.00981.
    PubMed    
    
    
    
13. HARRISON KS, Wijesekera N, Robinson AGJ, Santos VC, et al
    Impaired glucocorticoid receptor function attenuates herpes simplex virus 1 production during explant-induced reactivation from latency in female mice.
    J Virol. 2023 Oct 12:e0130523. doi: 10.1128/jvi.01305.
    PubMed     Abstract available
    
    
    September 2023
14. BOURNE N, Keith CA, Miller AL, Pyles RB, et al
    Boosting of vaginal HSV-2-specific B and T cell responses by intravaginal therapeutic immunization results in diminished recurrent HSV-2 disease.
    J Virol. 2023;97:e0066923.
    PubMed     Abstract available
    
    
    
15. DUNN LEM, Baines JD
    Herpes simplex virus 1 immediate early transcription initiation, pause-release, elongation, and termination in the presence and absence of ICP4.
    J Virol. 2023 Sep 27:e0096023. doi: 10.1128/jvi.00960.
    PubMed     Abstract available
    
    
    June 2023
16. SANDERS LS 3RD, Comar CE, Srinivas KP, Lalli J, et al
    Herpes Simplex Virus-1 ICP27 Nuclear Export Signal Mutants Exhibit Cell Type-Dependent Deficits in Replication and ICP4 Expression.
    J Virol. 2023 Jun 13:e0195722. doi: 10.1128/jvi.01957.
    PubMed     Abstract available
    
    
    
17. DE LA CRUZ NC, Mockel M, Niehues H, Rubsam M, et al
    Ex Vivo Infection of Human Skin Models with Herpes Simplex Virus 1: Accessibility of the Receptor Nectin-1 during Formation or Impairment of Epidermal Barriers Is Restricted by Tight Junctions.
    J Virol. 2023 Jun 8:e0026223. doi: 10.1128/jvi.00262.
    PubMed     Abstract available
    
    
    May 2023
18. WEISS E, Hennig T, Grassl P, Djakovic L, et al
    HSV-1 Infection Induces a Downstream Shift of Promoter-Proximal Pausing for Host Genes.
    J Virol. 2023;97:e0038123.
    PubMed     Abstract available
    
    
    April 2023
19. CUDDY SR, Cliffe AR
    The Intersection of Innate Immune Pathways with the Latent Herpes Simplex Virus Genome.
    J Virol. 2023 Apr 27:e0135222. doi: 10.1128/jvi.01352.
    PubMed     Abstract available
    
    
    
20. SANTOS VC, Ostler JB, Harrison KS, Jones C, et al
    Slug, a Stress-Induced Transcription Factor, Stimulates Herpes Simplex Virus 1 Replication and Transactivates a cis-Regulatory Module within the VP16 Promoter.
    J Virol. 2023 Apr 6:e0007323. doi: 10.1128/jvi.00073.
    PubMed     Abstract available
    
    
    February 2023
21. WANG J, Qin X, Huang Y, Zhang G, et al
    Sirt1 Negatively Regulates Cellular Antiviral Responses by Preventing the Cytoplasmic Translocation of Interferon-Inducible Protein 16 in Human Cells.
    J Virol. 2023;97:e0197522.
    PubMed     Abstract available
    
    
    
22. GRAMS TR, Edwards TG, Bloom DC
    HSV-1 LAT Promoter Deletion Viruses Exhibit Strain-Specific and LAT-Dependent Epigenetic Regulation of Latent Viral Genomes in Human Neurons.
    J Virol. 2023;97:e0193522.
    PubMed     Abstract available
    
    
    January 2023
23. BRUNIALTI M, Hofler T, Nascimento M, Trimpert J, et al
    Suicidal Phenotype of Proofreading-Deficient Herpes Simplex Virus 1 Polymerase Mutants.
    J Virol. 2023 Jan 4:e0135922. doi: 10.1128/jvi.01359.
    PubMed     Abstract available
    
    
    December 2022
24. NAZLI A, Chow R, Zahoor MA, Workenhe ST, et al
    LAMP3/CD63 Expression in Early and Late Endosomes in Human Vaginal Epithelial Cells Is Associated with Enhancement of HSV-2 Infection.
    J Virol. 2022;96:e0155322.
    PubMed     Abstract available
    
    
    
25. XU H, Wang J, Deng Y, Hou F, et al
    Two-Color CRISPR Imaging Reveals Dynamics of Herpes Simplex Virus 1 Replication Compartments and Virus-Host Interactions.
    J Virol. 2022 Dec 1:e0092022. doi: 10.1128/jvi.00920.
    PubMed     Abstract available
    
    
    November 2022
26. TAKESHIMA K, Maruzuru Y, Koyanagi N, Kato A, et al
    Redundant and Specific Roles of A-Type Lamins and Lamin B Receptor in Herpes Simplex Virus 1 Infection.
    J Virol. 2022 Nov 30:e0142922. doi: 10.1128/jvi.01429.
    PubMed     Abstract available
    
    
    
27. JAGGI U, Matundan HH, Lee DH, Ghiasi H, et al
    Blocking Autophagy in M1 Macrophages Enhances Virus Replication and Eye Disease in Ocularly Infected Transgenic Mice.
    J Virol. 2022;96:e0140122.
    PubMed     Abstract available
    
    
    October 2022
28. MOHNKE J, Stark I, Fischer M, Fischer PM, et al
    pUL36 Deubiquitinase Activity Augments Both the Initiation and the Progression of Lytic Herpes Simplex Virus Infection in IFN-Primed Cells.
    J Virol. 2022 Oct 31:e0096322. doi: 10.1128/jvi.00963.
    PubMed     Abstract available
    
    
    
29. DUNN LEM, Birkenheuer CH, Dufour R, Baines JD, et al
    Immediate Early Proteins of Herpes Simplex Virus Transiently Repress Viral Transcription before Subsequent Activation.
    J Virol. 2022 Oct 27:e0141622. doi: 10.1128/jvi.01416.
    PubMed     Abstract available
    
    
    August 2022
30. ZACHOS G, Koffa M, Preston CM, Clements JB, et al
    Retraction for Zachos et al., "Herpes Simplex Virus Type 1 Blocks the Apoptotic Host Cell Defense Mechanisms That Target Bcl-2 and Manipulates Activation of p38 Mitogen-Activated Protein Kinase to Improve Viral Replication".
    J Virol. 2022 Aug 30:e0104422. doi: 10.1128/jvi.01044.
    PubMed    
    
    
    
31. SIVASUBRAMANIAN MK, Monteiro R, Harrison KS, Plakkot B, et al
    Herpes Simplex Virus Type 1 Preferentially Enhances Neuro-Inflammation and Senescence in Brainstem of Female Mice.
    J Virol. 2022 Aug 17:e0108122. doi: 10.1128/jvi.01081.
    PubMed     Abstract available
    
    
    
32. MOCKEL M, De La Cruz NC, Rubsam M, Wirtz L, et al
    Herpes Simplex Virus 1 Can Bypass Impaired Epidermal Barriers upon Ex Vivo Infection of Skin from Atopic Dermatitis Patients.
    J Virol. 2022 Aug 15:e0086422. doi: 10.1128/jvi.00864.
    PubMed     Abstract available
    
    
    
33. RANA M, Setia M, Suvas PK, Chakraborty A, et al
    Diphenyleneiodonium Treatment Inhibits the Development of Severe Herpes Stromal Keratitis Lesions.
    J Virol. 2022 Aug 10:e0101422. doi: 10.1128/jvi.01014.
    PubMed     Abstract available
    
    
    
34. GIANOPULOS KA, Komala Sari T, Weed DJ, Pritchard SM, et al
    Conformational Changes in Herpes Simplex Virus Glycoprotein C.
    J Virol. 2022 Aug 1:e0016322. doi: 10.1128/jvi.00163.
    PubMed     Abstract available
    
    
    July 2022
35. BERBER E, Rouse BT
    Controlling Herpes Simplex Virus-Induced Immunoinflammatory Lesions Using Metabolic Therapy: a Comparison of 2-Deoxy-d-Glucose with Metformin.
    J Virol. 2022 Jul 11:e0068822. doi: 10.1128/jvi.00688.
    PubMed     Abstract available
    
    
    June 2022
36. WISE EL, Samolej J, Elliott G
    Herpes Simplex Virus 1 Expressing GFP-Tagged Virion Host Shutoff (vhs) Protein Uncouples the Activities of RNA Degradation and Differential Nuclear Retention of the Virus Transcriptome.
    J Virol. 2022 Jun 27:e0192621. doi: 10.1128/jvi.01926.
    PubMed     Abstract available
    
    
    May 2022
37. TESSEMA MB, Farrukee R, Andoniou CE, Degli-Esposti MA, et al
    Mouse Mx1 Inhibits Herpes Simplex Virus Type 1 Genomic Replication and Late Gene Expression In Vitro and Prevents Lesion Formation in the Mouse Zosteriform Model.
    J Virol. 2022 May 31:e0041922. doi: 10.1128/jvi.00419.
    PubMed     Abstract available
    
    
    
38. DOCHNAL S, Merchant HY, Schinlever AR, Babnis A, et al
    DLK-Dependent Biphasic Reactivation of Herpes Simplex Virus Latency Established in the Absence of Antivirals.
    J Virol. 2022 May 24:e0050822. doi: 10.1128/jvi.00508.
    PubMed     Abstract available
    
    
    
39. WHITFORD AL, Clinton CA, Kennedy EBL, Dochnal SA, et al
    Ex Vivo Herpes Simplex Virus Reactivation Involves a Dual Leucine Zipper Kinase-Dependent Wave of Lytic Gene Expression That Is Independent of Histone Demethylase Activity and Viral Genome Synthesis.
    J Virol. 2022 May 23:e0047522. doi: 10.1128/jvi.00475.
    PubMed     Abstract available
    
    
    
40. CHEN S, Deng Y, Chen H, Lin Y, et al
    Neuronal miR-138 Represses HSV-2 Lytic Infection by Regulating Viral and Host Genes with Mechanistic Differences from HSV-1.
    J Virol. 2022;96:e0034922.
    PubMed     Abstract available
    
    
    April 2022
41. MAEDA F, Kato A, Takeshima K, Shibazaki M, et al
    Role of the Orphan Transporter SLC35E1 in the Nuclear Egress of Herpes Simplex Virus 1.
    J Virol. 2022 Apr 27:e0030622. doi: 10.1128/jvi.00306.
    PubMed     Abstract available
    
    
    March 2022
42. MA Y, Li J, Dong H, Yang Z, et al
    PML Body Component Sp100A Restricts Wild-Type Herpes Simplex Virus 1 Infection.
    J Virol. 2022 Mar 30:e0027922. doi: 10.1128/jvi.00279.
    PubMed     Abstract available
    
    
    
43. KATZILIERIS-PETRAS G, Lai X, Rashidi AS, Verjans GMGM, et al
    Microglia Activate Early Antiviral Responses upon Herpes Simplex Virus 1 Entry into the Brain to Counteract Development of Encephalitis-Like Disease in Mice.
    J Virol. 2022;96:e0131121.
    PubMed     Abstract available
    
    
    
44. DHANUSHKODI NR, Prakash S, Srivastava R, Coulon PA, et al
    Antiviral CD19(+)CD27(+) Memory B Cells Are Associated with Protection from Recurrent Asymptomatic Ocular Herpesvirus Infection.
    J Virol. 2022;96:e0205721.
    PubMed     Abstract available
    
    
    
45. TORMANEN K, Matundan HH, Wang S, Jaggi U, et al
    Small Noncoding RNA (sncRNA1) within the Latency-Associated Transcript Modulates Herpes Simplex Virus 1 Virulence and the Host Immune Response during Acute but Not Latent Infection.
    J Virol. 2022 Mar 7:e0005422. doi: 10.1128/jvi.00054.
    PubMed     Abstract available
    
    
    February 2022
46. TORMANEN K, Wang S, Matundan HH, Yu J, et al
    Herpes Simplex Virus 1 Small Noncoding RNAs 1 and 2 Activate the Herpesvirus Entry Mediator Promoter.
    J Virol. 2022;96:e0198521.
    PubMed     Abstract available
    
    
    January 2022
47. GMYREK GB, Predki P, Gershburg E, Carr DJJ, et al
    Noncognate Signals Drive Enhanced Effector CD8(+) T Cell Responses through an IFNAR1-Dependent Pathway after Infection with the Prototypic Vaccine, 0DeltaNLS, against Herpes Simplex Virus 1.
    J Virol. 2022 Jan 19:JVI0172421. doi: 10.1128/JVI.01724.
    PubMed     Abstract available
    
    
    
48. BIRKENHEUER CH, Dunn L, Dufour R, Baines JD, et al
    The ICP22 protein of Herpes Simplex Virus 1 decreases RNA Polymerase Processivity.
    J Virol. 2022 Jan 12:jvi0219121. doi: 10.1128/jvi.02191.
    PubMed     Abstract available
    
    
    December 2021
49. VAN GENT M, Chiang JJ, Muppala S, Chiang C, et al
    The US3 kinase of Herpes Simplex virus phosphorylates the RNA sensor RIG-I to suppress innate immunity.
    J Virol. 2021 Dec 22:JVI0151021. doi: 10.1128/JVI.01510.
    PubMed     Abstract available
    
    
    
50. WIRTZ L, De La Cruz NC, Mockel M, Knebel-Morsdorf D, et al
    Susceptibility of human and murine dermal fibroblasts to Herpes simplex Virus 1 in the absence and presence of extracellular matrix.
    J Virol. 2021 Dec 15:JVI0206821. doi: 10.1128/JVI.02068.
    PubMed     Abstract available
    
    
    
51. HAYES CK, Giraldo D, Wilcox DR, Longnecker R, et al
    The Astrocyte Type I Interferon Response is Essential for Protection Against Herpes Simplex Encephalitis.
    J Virol. 2021 Dec 8:JVI0178321. doi: 10.1128/JVI.01783.
    PubMed     Abstract available
    
    
    November 2021
52. ROLLER RJ, Hassman T, Haugo-Crooks A
    Cell Culture Evolution of a Herpes Simplex Virus 1 (HSV-1)/Varicella-Zoster Virus (VZV) UL34/ORF24 Chimeric Virus Reveals Novel Functions for HSV Genes in Capsid Nuclear Egress.
    J Virol. 2021;95:e0095721.
    PubMed     Abstract available
    
    
    
53. ARII J, Takeshima K, Maruzuru Y, Koyanagi N, et al
    Role of the arginine cluster in the disordered domain of Herpes Simplex Virus 1 UL34 for the recruitment of ESCRT-III for viral primary envelopment.
    J Virol. 2021 Nov 3:JVI0170421. doi: 10.1128/JVI.01704.
    PubMed     Abstract available
    
    
    September 2021
54. MATUNDAN HH, Wang S, Jaggi U, Yu J, et al
    Suppression of CD80 Expression by ICP22 Affects Herpes Simplex Virus Type 1 Replication and CD8(+)IFN-gamma(+) Infiltrates in the Eyes of Infected Mice but Not Latency Reactivation.
    J Virol. 2021;95:e0103621.
    PubMed     Abstract available
    
    
    August 2021
55. FAN Q, Longnecker R, Connolly SA
    Herpes simplex virus glycoprotein B (gB) mutations define structural sites in domain I, the membrane proximal region, and the cytodomain that regulate entry.
    J Virol. 2021 Aug 25:JVI0105021. doi: 10.1128/JVI.01050.
    PubMed     Abstract available
    
    
    
56. DE LA CRUZ NC, Mockel M, Wirtz L, Sunaoglu K, et al
    Ex vivo infection of human skin with herpes simplex virus 1 reveals mechanical wounds as insufficient entry portals via the skin surface.
    J Virol. 2021 Aug 11:JVI0133821. doi: 10.1128/JVI.01338.
    PubMed     Abstract available
    
    
    
57. VU A, White S, Cassmann T, Roller RJ, et al
    Herpes Simplex Virus 1 UL34 Mutants That Affect Membrane Budding Regulation and Nuclear Lamina Disruption.
    J Virol. 2021;95:e0087321.
    PubMed     Abstract available
    
    
    April 2021
58. MEIER AF, Tobler K, Michaelsen K, Vogt B, et al
    Herpes Simplex Virus Type 1 Co-Infection Modifies Adeno-Associated Virus Genome End Recombination.
    J Virol. 2021 Apr 14. pii: JVI.00486-21. doi: 10.1128/JVI.00486.
    PubMed     Abstract available
    
    
    
59. IKEDA H, Uchida H, Okubo Y, Shibata T, et al
    Antibody Screening System Using a Herpes Simplex Virus (HSV)-Based Probe To Identify a Novel Target for Receptor-Retargeted Oncolytic HSVs.
    J Virol. 2021;95.
    PubMed     Abstract available
    
    
    February 2021
60. ARACHCHIGE SP, Henke W, Kalamvoki M, Stephens EB, et al
    Structural Domains of the Herpes Simplex Type 1 gD Protein that Restrict HIV-1 Particle Infectivity.
    J Virol. 2021 Feb 3. pii: JVI.02355-20. doi: 10.1128/JVI.02355.
    PubMed     Abstract available
    
    
    January 2021
61. ZHENG W, Klammer AM, Naciri JN, Yeung J, et al
    Correction for Zheng et al., "Patterns of Herpes Simplex Virus 1 Infection in Neural Progenitor Cells".
    J Virol. 2021;95.
    PubMed    
    
    
    
62. SUMBRIA D, Berber E, Rouse BT
    Supplementing the Diet with Sodium Propionate Suppresses the Severity of Viral Immuno-inflammatory Lesions.
    J Virol. 2021;95.
    PubMed     Abstract available
    
    
    
63. OSTLER JB, Thunuguntla P, Hendrickson BY, Jones C, et al
    Transactivation of Herpes Simplex Virus 1 (HSV-1) Infected Cell Protein 4 Enhancer by Glucocorticoid Receptor and Stress-Induced Transcription Factors Requires Overlapping Kruppel-Like Transcription Factor 4/Sp1 Binding Sites.
    J Virol. 2021;95.
    PubMed     Abstract available
    
    
    December 2020
64. DOGRAMMATZIS C, Saleh S, Deighan C, Kalamvoki M, et al
    Diverse populations of extracellular vesicles with opposite functions during herpes simplex virus 1 infection.
    J Virol. 2020 Dec 23. pii: JVI.02357-20. doi: 10.1128/JVI.02357.
    PubMed     Abstract available
    
    
    
65. MARUZURU Y, Koyanagi N, Kato A, Kawaguchi Y, et al
    Role of the DNA Binding Activity of Herpes Simplex Virus 1 VP22 in Evading AIM2-Dependent Inflammasome Activation Induced by the Virus.
    J Virol. 2020 Dec 9. pii: JVI.02172-20. doi: 10.1128/JVI.02172.
    PubMed     Abstract available
    
    
    
66. ABRAHAMSON EE, Zheng W, Muralidaran V, Ikonomovic MD, et al
    Modeling Abeta42 Accumulation in Response to Herpes Simplex Virus 1 Infection: 2D or 3D?
    J Virol. 2020 Dec 2. pii: JVI.02219-20. doi: 10.1128/JVI.02219.
    PubMed     Abstract available
    
    
    November 2020
67. EL BILALI N, Khadivjam B, Bonneil E, Thibault P, et al
    Proteomics of Herpes Simplex Virus Type 1 Nuclear Capsids.
    J Virol. 2020 Nov 25. pii: JVI.01842-19. doi: 10.1128/JVI.01842.
    PubMed     Abstract available
    
    
    
68. DE LA CRUZ N, Knebel-Morsdorf D
    Endocytic Internalization of Herpes Simplex Virus 1 in Human Keratinocytes at Low Temperature.
    J Virol. 2020 Nov 25. pii: JVI.02195-20. doi: 10.1128/JVI.02195.
    PubMed     Abstract available
    
    
    
69. BARROZO ER, Nakayama S, Singh P, Neumann DM, et al
    Herpes Simplex Virus 1 microRNA miR-H8 is Dispensable for Latency and Reactivation in Vivo.
    J Virol. 2020 Nov 18. pii: JVI.02179-20. doi: 10.1128/JVI.02179.
    PubMed     Abstract available
    
    
    
70. UCHE IK, Fowlkes N, Vu L, Watanabe T, et al
    The Novel Oncolytic Herpes Simplex Virus Type-1 (HSV-1) VC2 Promotes Long-lasting, Systemic Anti-melanoma Tumor Immune Responses and Increased Survival in an Immunocompetent B16F10-derived Mouse Melanoma Model.
    J Virol. 2020 Nov 11. pii: JVI.01359-20. doi: 10.1128/JVI.01359.
    PubMed     Abstract available
    
    
    
71. WATANABE M, Arii J, Takeshima K, Fukui A, et al
    Prohibitin-1 Contributes to the Cell-to-Cell Transmission of Herpes Simplex Virus 1.
    J Virol. 2020 Nov 11. pii: JVI.01413-20. doi: 10.1128/JVI.01413.
    PubMed     Abstract available
    
    
    
72. FRIEDEL CC, Whisnant AW, Djakovic L, Rutkowski AJ, et al
    Dissecting Herpes Simplex Virus 1-Induced Host Shutoff at the RNA Level.
    J Virol. 2020 Nov 4. pii: JVI.01399-20. doi: 10.1128/JVI.01399.
    PubMed     Abstract available
    
    
    October 2020
73. KIM DJ, Khoury-Hanold W, Jain PC, Klein J, et al
    RUNX Binding Sites Are Enriched in Herpesvirus Genomes, and RUNX1 Overexpression Leads to Herpes Simplex Virus 1 Suppression.
    J Virol. 2020;94.
    PubMed     Abstract available
    
    
    
74. BORUCHOWICZ H, Hawkins J, Cruz-Palomar K, Lippe R, et al
    The XPO6 Exportin Mediates Herpes Simplex Virus 1 gM Nuclear Release Late in Infection.
    J Virol. 2020;94.
    PubMed     Abstract available
    
    
    
75. ZHAO J, Zhu L, Wijesekera N, Jones C, et al
    Specific Akt Family Members Impair Stress-Mediated Transactivation of Viral Promoters and Enhance Neuronal Differentiation: Important Functions for Maintaining Latency.
    J Virol. 2020;94.
    PubMed     Abstract available
    
    
    
76. BAGRI P, Ghasemi R, McGrath JJC, Thayaparan D, et al
    Estradiol enhances anti-viral CD4(+) tissue-resident memory T cell responses following mucosal herpes simplex virus 2 vaccination through an IL-17-mediated pathway.
    J Virol. 2020 Oct 7. pii: JVI.01206-20. doi: 10.1128/JVI.01206.
    PubMed     Abstract available
    
    
    
77. TEBALDI G, Pritchard SM, Nicola AV
    Herpes simplex virus entry by a non-conventional endocytic pathway.
    J Virol. 2020 Oct 7. pii: JVI.01910-20. doi: 10.1128/JVI.01910.
    PubMed     Abstract available
    
    
    
78. STINN T, Kuntz S, Varon D, Huang ML, et al
    Subclinical genital herpes shedding in HIV/HSV-2 co-infected women during antiretroviral therapy (ART) is associated with an increase in HIV tissue reservoirs and potentially promotes HIV evolution.
    J Virol. 2020 Oct 7. pii: JVI.01606-20. doi: 10.1128/JVI.01606.
    PubMed     Abstract available
    
    
    September 2020
79. ARII J, Fukui A, Shimanaka Y, Kono N, et al
    Role of phosphatidyl-ethanolamine biosynthesis in herpes simplex virus 1 infected cells on progeny virus morphogenesis in the cytoplasm and on viral pathogenicity in vivo.
    J Virol. 2020 Sep 30. pii: JVI.01572-20. doi: 10.1128/JVI.01572.
    PubMed     Abstract available
    
    
    
80. GMYREK GB, Filiberti A, Montgomery M, Chitrakar A, et al
    HSV-1 0DeltaNLS Live-Attenuated Vaccine Protects Against Ocular HSV-1 Infection in the Absence of Neutralizing Antibody in HSV-1 gB T Cell Receptor-Specific Transgenic Mice.
    J Virol. 2020 Sep 30. pii: JVI.01000-20. doi: 10.1128/JVI.01000.
    PubMed     Abstract available
    
    
    
81. HARANCHER MR, Packard JE, Cowan SP, DeLuca NA, et al
    Antiviral Properties of the LSD1 Inhibitor SP-2509.
    J Virol. 2020;94.
    PubMed     Abstract available
    
    
    August 2020
82. SHIBAZAKI M, Kato A, Takeshima K, Ito J, et al
    Phosphoregulation of a Conserved Herpesvirus Tegument Protein by a Virally Encoded Protein Kinase in Viral Pathogenicity and Potential Linkage between Its Evolution and Viral Phylogeny.
    J Virol. 2020;94.
    PubMed     Abstract available
    
    
    July 2020
83. TORMANEN K, Wang S, Jaggi U, Ghiasi H, et al
    Restoring Herpesvirus Entry Mediator (HVEM) Immune Function in HVEM(-/-) Mice Rescues Herpes Simplex Virus 1 Latency and Reactivation Independently of Binding to Glycoprotein D.
    J Virol. 2020;94.
    PubMed     Abstract available
    
    
    
84. ZHENG W, Klammer AM, Naciri JN, Yeung J, et al
    Patterns of Herpes Simplex Virus 1 Infection in Neural Progenitor Cells.
    J Virol. 2020;94.
    PubMed     Abstract available
    
    
    June 2020
85. SURYAWANSHI RK, Koujah L, Patil CD, Ames JM, et al
    Bacterial Pigment Prodigiosin Demonstrates a Unique Antiherpesvirus Activity That Is Mediated through Inhibition of Prosurvival Signal Transducers.
    J Virol. 2020;94.
    PubMed     Abstract available
    
    
    
86. ZHOU X, Wang L, Zou W, Chen X, et al
    hnRNPA2B1 Associated with Recruitment of RNA into Exosomes Plays a Key Role in Herpes Simplex Virus 1 Release from Infected Cells.
    J Virol. 2020;94.
    PubMed     Abstract available
    
    
    
87. JAN FADA B, Kaadi E, Samrat SK, Zheng Y, et al
    Effect of SUMO-SIM Interaction on the ICP0-Mediated Degradation of PML Isoform II and Its Associated Proteins in Herpes Simplex Virus 1 Infection.
    J Virol. 2020;94.
    PubMed     Abstract available
    
    
    April 2020
88. DHANUSHKODI NR, Srivastava R, Prakash S, Roy S, et al
    High Frequency of Gamma Interferon-Producing PLZF(lo)RORgammat(lo) Invariant Natural Killer 1 Cells Infiltrating Herpes Simplex Virus 1-Infected Corneas Is Associated with Asymptomatic Ocular Herpesvirus Infection.
    J Virol. 2020;94.
    PubMed     Abstract available
    
    
    
89. POWELL-DOHERTY RD, Abbott ARN, Nelson LA, Bertke AS, et al
    Amyloid-beta and p-Tau Anti-Threat Response to Herpes Simplex Virus 1 Infection in Primary Adult Murine Hippocampal Neurons.
    J Virol. 2020;94.
    PubMed     Abstract available
    
    
    March 2020
90. DONG X, Zhou J, Qin HB, Xin B, et al
    Anterograde Viral Tracer Herpes Simplex Virus 1 Strain H129 Transports Primarily as Capsids in Cortical Neuron Axons.
    J Virol. 2020;94.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Herpes simplex Infection is free of charge.